| ||||||||||||||
|
 |
 |
|
"The BAERVELDT® glaucoma implant is effective in lowering the IOP in patients with intractable glaucomas. Hypotony and other complications are common, which also have been reported in other nonvalved glaucoma drainage implants. However, the majority of these complications did not affect surgical outcome."9 Siegner SW et al. Ophthalmology. 1995;102(9):1298-1307. The BAERVELDT® glaucoma implant is indicated for use in patients with medically uncontrollable glaucoma and poor surgical prognosis, such as, but not limited to: neovascular glaucoma; aphakic/pseudophakic glaucomas; failed conventional surgery, congenital glaucoma; and secondary glaucoma due to uveitis, epithelial downgrowth, etc.Contraindications include bacterial conjunctivitis, bacterial corneal ulcers, endophthalmitis, orbital cellulitis, bacteremia or septicemia, active scleritis and/or no light perception. Reported complications during and after surgery include, but are not limited to: choroidal hemorrhage, hyphema, serous choroidal effusion, hypotony, flat anterior chamber, phthisis bulbi, retinal detachment, endophthalmitis, tube erosion, tube touch to cornea, tube block by iris or vitreous, bullous keratopathy, uveitis, and diplopia.
|
